Data as of Aug 27
| +0.02 / +0.52%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +284.62% increase from the last price of 3.90.
The current consensus among 1 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.